ArticleBMC infectious diseases2026
Factors influencing pre-exposure prophylaxis adherence among female sex workers in Kinshasa, Democratic Republic of the Congo: a prospective cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundFemale sex workers (FSWs) in the Democratic Republic of the Congo (DRC) bear a disproportionately high burden of HIV infection. Daily oral pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy, but its public health impact depends on sustained adherence. Evidence of PrEP adherence among FSWs in the DRC remains limited. This study assessed PrEP adherence over time and identified factors associated with adherence among FSWs in Kinshasa.
methodsWe conducted a 6-month prospective cohort study among 120 FSWs receiving PrEP at four client-friendly healthcare centers in Kinshasa in 2024, hereafter referred to as Clinic A, Clinic B, Clinic C, and Clinic D. Adherence was assessed using self-reported missed doses over the previous seven days and pill count. Retention in care was documented at months 3 and 6. Multivariable logistic regression guided by a directed acyclic graph (DAG) was used to identify factors associated with adherence at inclusion, month 3, and month 6.
resultsThe median age of participants was 28 years (interquartile range [IQR]: 24-37). Based on pill count, adherence increased from 80.0% at inclusion to 93.6% at month 3 and 95.1% at month 6, whereas self-reported adherence declined over time. In DAG-informed models, clinic site was significantly associated with adherence at baseline. Compared with Clinic A, participants attending Clinic B (adjusted odds ratio [aOR] = 5.7; 95% confidence interval [CI]: 1.4-22.3) and Clinic C (aOR = 11.4; 95% CI: 2.1-61.1) were more likely to be adherent. No independent predictors were identified at later follow-up points. Retention in care was 92% at month 3 and 84% at month 6.
conclusionPrEP adherence among FSWs in Kinshasa was high and improved over time when measured objectively. Baseline site-level differences underscore the importance of contextual and programmatic factors in supporting adherence. These findings provide evidence to inform the optimization and scale-up of PrEP delivery models for key populations in the DRC and similar settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.